SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys reported plans for thousands of job cuts and broader cost savings are a dominant topic ahead of earnings. Traders debate whether the restructuring could improve efficiency or signals deeper business pressures, while others point to the stocks recent rebound and technical momentum.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs better-than-expected quarterly results and stronger forward guidance are driving renewed attention, with traders viewing the outlook as support for AI-related semiconductor equipment demand. The reaction is broadly upbeat, though some remain wary after the stocks steep pullback and ongoing concerns about chipmakers capital spending and sector volatility.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

Analyst downgrades following UiPaths Investor Day are driving debate over whether its agentic-AI and orchestration products can translate into faster growth. Bulls view the selloff as overdone given the companys products and financial position, while skeptics say growth and customer monetization have yet to provide convincing proof.

Pinterest, Inc. engages in the operation of an AI-powered visual search and discovery platform. It enables users to find inspiration, curate ideas, search for products, and discover content through visual recommendations. The company was founded by Benjamin Silbermann, Paul Cahill Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is under pressure after its latest quarterly results missed revenue expectations and its softer outlook prompted analyst target cuts, despite record monthly users. Traders are debating whether user growth can translate into stronger ad monetization, with some viewing the selloff as an overreaction and others questioning the companys execution.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

IBB is drawing attention for its biotech-sector rally and breakout near record highs, with traders citing rotation into healthcare and strength across biotech stocks. Call-heavy options activity has added interest, though traders are debating whether it signals bullish positioning or hedging.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowes is drawing attention as a rate-sensitive housing and home-improvement stock: traders see potential support from easing yields and sector rotation, while others point to delayed renovations and weak contractor demand. The community is split between dip-buyers anticipating a rebound and bears who see continued pressure from a sluggish housing market.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

AMAT is drawing attention after a sharp semiconductor-equipment selloff, with traders questioning whether AI-related fab spending and chipmaker capex can sustain demand for its tools. Put-heavy options activity and calls for further declines contrast with dip-buyers pointing to the recent bounce and long-term AI demand; the catalyst remains a concern, not a confirmed slowdown in orders.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDBs CEO CJ Desai abruptly left to join Meta, prompting a sharp selloff and debate over leadership uncertainty versus whether the reaction was overdone, since former CEO Dev Ittycheria returned as interim chief and guidance was reaffirmed. Investor Day product announcements and buyback news fueled dip-buying and hopes of a rebound, while some traders remain concerned about the CEO transition and valuation.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Traders are questioning whether layoffs and contractor cuts could weigh on Oktas per-seat identity revenue, undermining the AI-agent growth story; others argue that AI agents will create new demand for identity security. Put-heavy options chatter and concern about the stocks weakness point to a cautious tone, but the debate remains mixed.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs sharp rebound after its earnings-related selloff is drawing attention, despite the quarters miss and lowered guidance. Bulls point to the companys portfolio review and possible asset sales as turnaround drivers, while skeptics remain concerned about growth and execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK Reportedly Pulls Application For Drug Touted By Trump As Potential Treatment For Autism

Equity

According to a report from the Wall Street Journal on Thursday, GSK asked the FDA to pull its application for leucovorin calcium because it no longer markets the medicine.

Fidelity Covington Trust - Fidelity Enhanced International ETF

Neutral Sentiment

<ul class="summary-bullets"><li>FDA approved leucovorin in the treatment of cerebral folate transport deficiency last month but not in autism.</li><li>Leucovorin garnered attention in the latter half of 2025 after Donald Trump and his administration promoted it as an "exciting" and “promising” therapeutic for autism.</li><li>According to research published in The Lancet, outpatient leucovorin prescriptions for children aged 5–17 years increased by 71% following the press briefing in September.</li></ul>UK drugmaker GSK Plc (GSK) has withdrawn its application for the drug leucovorin calcium touted by President Trump as a potential treatment for autism.GSK asked the U.S. Food and Drug Administration to pull its application for leucovorin calcium because it no longer markets the medicine, a filing on the FDA website shows.The news was first reported by The Wall Street Journal. &nbsp;<h2 class="st-heading-2">Leucovorin Approval And Claims</h2>According <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/pharma/gsk-nixes-application-for-drug-touted-by-trump-for-autism-4d5bdead">to </a>WSJ, GSK said in September that it would submit an application for the drug in the treatment of cerebral folate transport deficiency following a request from the FDA. The agency approved the drug for the condition last month, but not for autism. The company, however, hasn’t sold the drug since 1999, the report noted. &nbsp;A GSK spokesperson reportedly told the newspaper that the company never intended to sell the drug again. Meanwhile, a spokesperson for the U.S. Department of Health and Human Services told the paper that GSK’s decision has no bearing on generic versions of the drug for patients with cerebral folate deficiency.Leucovorin garnered attention in the latter half of 2025 after Donald Trump and his administration promoted it as an "exciting" and “promising” therapeutic for autism. According to <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00243-6/fulltext">research</a> published in The Lancet, outpatient leucovorin prescriptions for children aged 5–17 years increased by 71% following the press briefing in September where Trump made his claims with Robert F Kennedy Jr.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around GSK stock stayed within the ‘bearish’ territory, while message volume remained at ‘low’ levels.<a href="https://stocktwits.com/symbol/GSK">GSK stock</a> has gained 69% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-heads-for-8th-straight-week-of-price-decline/cZJWlLZRIsZ">TSLA Stock Heads For 8th Straight Week Of Price Decline — What’s Driving The Selloff?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of GSK plc is displayed on a smartphone screen, on April 26, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

American Century ETF Trust - Avantis International Equity ETF

Fidelity Enhanced International ETF

Glaxosmithkline plc - ADR

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$38.86
Prev Close	$39.01
Open	$38.67
Dividend Yield	N/A
50-Day Moving Average	$40.17
Beta	N/A
Avg. Volume	1.34M
PE Ratio	N/A

52-Week High	$42.09
52-Week Low	$34.36
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

FENI Fundamentals